Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
about
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in MiceCross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in MiceBaths salts, spice, and related designer drugs: the science behind the headlines.High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with humSynthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and ratsPhenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market.The Changing Face of Recreational Drug Use.Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4.Recent developments in urinalysis of metabolites of new psychoactive substances using LC-MS.Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18.In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.Detection of main metabolites of XLR-11 and its thermal degradation product in human hepatoma HepaRG cells and human urine.Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.Synthetic Pot: Not Your Grandfather's Marijuana.The Influence of Synthetic Cannabinoid UR-144 on Human Psychomotor Performance--A Case Report Demonstrating Road Traffic Risks.Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential.Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro AssaysDiscriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes.Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.Short-Term Curcumin Gavage Sensitizes Insulin Signaling in Dexamethasone-Treated C57BL/6 Mice.Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ9 -tetrahydrocannabinol.Δ(9)-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic cannabinoids in rats.Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.Determination of urinary metabolites of XLR-11 by liquid chromatography-quadrupole time-of-flight mass spectrometry.Retrospective Chart Review of Synthetic Cannabinoid Intoxication with Toxicologic Analysis.Differentiation of AB-FUBINACA and its five positional isomers using liquid chromatography–electrospray ionization-linear ion trap mass spectrometry and triple quadrupole mass spectrometry.Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ-THCCytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11
P2860
Q30148688-E3414EC9-75DB-4A46-8670-82C9F53B1CDCQ33583810-F68A4AF6-1F37-4299-B83F-2289AD3F7EE6Q34115633-CDC7A652-A1D2-4373-B422-74E01FCE11FDQ34373631-C680AEC0-7CC2-41DD-A7D0-A59D455CDDF0Q34482035-D2F2307B-5855-4FFE-8B1C-A1C0D64CCD93Q34491601-EDA4CD4E-2FD9-4A19-A89F-44D8BB6AD391Q34514221-3B325483-0953-4108-B5D8-5069F7317E51Q34617484-41807B8D-B38D-4F82-BABE-7E6172FB2F59Q34675734-0EFCFDF9-BEB8-4482-963B-024F671F56C5Q35287466-A847D385-991A-41CC-AE7B-1866C2C14276Q35836423-55628D74-D4A0-4368-93B0-A887F0C9A04DQ37078847-C692C13C-D598-42BE-AECA-718C3D88DD34Q37408099-619AF3E0-4079-4E64-BD87-F341F28DCDE4Q38260819-68544DC3-154A-47D1-B1D0-754049DC5D83Q38611708-E32E6AE1-19FE-4034-BB81-514C179CF6C9Q38616637-6742D347-4020-4D3F-A2CC-847DC5D7ED25Q38918740-2F9A72A7-081B-49DE-9573-2B4E36D27F0DQ38983630-5BAAE8E7-EFD0-46BD-8CDD-28710454C93EQ38983634-44ACA3BC-60BE-4183-B6A3-16B4CD57D6E5Q39120303-1DF1FE63-38FB-4A75-848D-44DD2D60D558Q41187536-E221E9C5-B2B7-4223-9AA1-D2AFBCED85ECQ41774329-9D7D3A35-3202-4DE1-994D-E5A21196DAA3Q42581822-22C64A69-4955-4B13-A5C9-A3379F296232Q42713279-3F62ECB0-1FC8-4877-959F-77B7FF9F5C5EQ45035724-39477621-D56E-46F9-BB76-98DBA3113D6FQ45050576-E3690F31-E36C-467B-9D99-106C0BCA4EE0Q47598189-23A912CD-91AC-431F-B3B3-1C7F19B65F45Q48020201-DF52DACE-CDA3-4710-B6E2-497A61BCBE11Q48137778-99F7A9A4-0FE2-4CA6-B41F-1F1E4A53A54AQ48269342-D9EA3FC3-E1B0-492D-B756-5D865AB246D9Q50014079-3F3B7B05-1801-4CB7-8246-EFFE082D1BDAQ50117427-1F3492A7-2954-4D9F-BD91-0F9B6B0371F4Q50259275-69022C50-FA20-4CA1-8B9B-9C9DA289E643Q52651312-1BCE893C-13B4-4589-A4DB-AEE05801202AQ53094148-9ED3AB2E-2D03-41EC-83D5-98E615E1DBCBQ53188520-194AC913-59C4-4841-AF55-859A55A8F30AQ55116445-C689BD51-3D0D-4DDE-B79D-A71CED084F93Q55362032-3E2BE7AF-EEFD-4A0B-BFBA-57ADF3F5262CQ57491573-67C1D832-DD0D-4380-9A64-7BF91657BC63Q57814871-BEEC57BA-A10E-4FA1-88F4-C7309938A992
P2860
Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cannabinoids in disguise: Δ9-t ...... hylcyclopropyl ketone indoles.
@en
Cannabinoids in disguise: Δ9-t ...... hylcyclopropyl ketone indoles.
@nl
type
label
Cannabinoids in disguise: Δ9-t ...... hylcyclopropyl ketone indoles.
@en
Cannabinoids in disguise: Δ9-t ...... hylcyclopropyl ketone indoles.
@nl
prefLabel
Cannabinoids in disguise: Δ9-t ...... hylcyclopropyl ketone indoles.
@en
Cannabinoids in disguise: Δ9-t ...... hylcyclopropyl ketone indoles.
@nl
P2093
P2860
P50
P1433
P1476
Cannabinoids in disguise: Δ9-t ...... hylcyclopropyl ketone indoles.
@en
P2093
Julie A Marusich
Katherine N Moore
Timothy W Lefever
P2860
P304
P356
10.1016/J.NEUROPHARM.2013.07.022
P577
2013-08-02T00:00:00Z